IndraLab

Statements



reach
"Alternatively, knockdown of DUBA expression by ASO may inhibit the development of TNBS colitis through downregulation of pathogenic IL-17 production, since DUBA has been shown to function as a posttranslational brake against IL-17 production by T cells."